Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

ESAOTE LANCE NOUVEAU CRYSTALINE À LA CAISSE ENREGISTRRICE ÉLECTRONIQÎCHE 2014

Press releases may be edited for formatting or style | March 03, 2014

Ultrasound Workshop @ ECR
For more information visit: http://www.esaote.com/media/docs/ECR2014_Workshop_EsaoteBracco_invitation.pdf

About Esaote
stats
DOTmed text ad

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.

stats

With €325.3 million consolidated sales in 2012 (of which 70% were generated from international markets), Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,360 employees, 20% of which are employed in R&D activities. Esaote has industrial and research units in Italy (Genoa, Florence, Naples), the Netherlands (Maastricht) and China (Shenzhen). Esaote is internationally recognised as one of the "Top Ten" diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centres and universities. Esaote has filed more than120 international patents.

Information about the Esaote Group and its products is available at www.esaote.com

Virtual Navigator is not available for sales in the USA.
EchoLaser is a product of Elesta joint venture Esaote - El-En.
EchoLaser is not yet available for sales in the USA.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries.
For further details, please contact your Esaote sales representative.

Back to HCB News

You Must Be Logged In To Post A Comment